Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 0

New Approaches inDiabetic Maculopathy

DiabetikMakülopatide Yeni Yaklaşımlar

Pages
32–42
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A clear definition of diabetic maculopathy is necessary for diagnosis, decision of proper treatment and prediction of prognosis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic maculopathy is one of the most significant causes in visual deterioration in diabetic patients.
📊
Key Findings & Data:Diabetic maculopathy can be seen in every stage of diabetic retinopathy and causes center of macula involved diabetic macular edema in a rate of 40%.
💡
Conclusion & Impact:A clear definition of diabetic maculopathy is necessary for diagnosis, decision of proper treatment and prediction of prognosis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetic maculopathy is one of the most significant causes in visual deterioration in diabetic patients. Diabetic maculopathy can be seen in every stage of diabetic retinopathy and causes center of macula involved diabetic macular edema in a rate of 40%. There are many types of diabetic macular edema including focal-diffuse edema, central involved or not-involved edema, cystoid edema, tractional edema, foveal detachment, ischemic maculopathy. Macular edema and macular ischemia was defined as two types of maculopathy by traditional methods based on fundus examination and fundus fluorescein angiography In recent years, detailed description and classifications of diabetic maculopathy has been made and especially tractional maculopathy notion has emerged with the widespread use of optic coherence tomography. A clear definition of diabetic maculopathy is necessary for diagnosis, decision of proper treatment and prediction of prognosis

Özet

Diabetik makülopati diabet hastalarında görme kaybında rol oynayan en önemli nedenlerin başında gelmektedir. Diabetik retinopatinin her evresinde karşımıza çıkabilen diabetik makulopati %40 oranında makülanın merkezini tutan diabetik maküla ödemine sebep olmaktadır. Diabetik maküla ödemi tanımlamasında fokal-diffüz ödem, fovea santralini etkileyenkoruyan ödem, kistoid maküla ödemi, traksiyonel ödem, foveal dekolman, iskemik maküla ödemi gibi farklı tanımlamalar yer almaktadır. Diabetik makülopatide fundus muayenesi ve fundus floresein anjiografi temel alınarak yapılan geleneksel tanımlamada maküla ödemi ve maküla iskemisi gruplandırması öne çıkmaktaydı. Son yıllarda ise optik koherens tomografinin yaygın kullanımıyla diabetik makülopatinin tanımlama ve sınıflandırılmasında detaylandırmalara gidilmiş özellikle traksiyonel makülopati kavramı ortaya çıkmıştır. Diabetik makulopatinin iyi tanımlanması, tanı, uygun tedavi ve muhtemel prognozu belirlemek amacıyla gereklidir

🔖

Cite This Article

ÖZDEK, Ş., YALÇIN, G. (2015). New Approaches inDiabetic Maculopathy. Retina-Vitreus, Cilt: 23 - Sayı: 0, 32–42. https://ajindex.com/articles/308045

References (11)

  1. Bhagat N, Grigorian RA, Tutela A, et al. Diabetic macular edema: patho- genesis and treatment. Surv Ophthalmol 2009;54:1-32.
  2. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91:1464-74.
  3. Klein R, Knudtson MD, Lee KE, et al. The wisconsin epidemiologic study of diabetic retinopathy xxııı: the twenty-five-year ıncidence of macular edema in persons with type 1 diabetes Ophthalmology 2009;116:497-503.
  4. Zhang X, Zeng H, Bao S, et al. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci 2014;4:27. Kanski J, Bowling B. Retinal vascular disease Gabbedy R, Cook L. Cli- nical ophthalmology A systematic approach 7 th ed. Elsevier Saunders 2011:537-42.
  5. Browning DJ, Altaweel MM, Bressler NM, et al. Diabetic Retinopathy Clinical Research Network. Diabetic macular edema: What is focal and what is diffuse? Am J Ophthalmol 2008;146:649-55. Diabetic Retinopathy Clinical Research Network; Writing Committee, Aiello LP, Beck RW, Bressler NM, Browning DJ, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for cen- ter-involved diabetic macular edema. Ophthalmology 2011;118:5-14.
  6. Bandello F, Pognuz R, Polito A, et al. Diabetic macular edema: classifica- tion, medical and laser therapy. Semin Ophthalmol 2003;18:251-8.
  7. Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in diabetic cystoid macular oedema. Acta Ophthalmol Scand 2005;83:63-6. Early Treatment Diabetic Retinopathy Study Research Group Early pho- tocoagulation for diabetic retinopathy. ETDRS report number 9. Oph- thalmology 1991;98:766-85.
  8. Wilkinson CP, Ferris FL 3rd, Klein RE, et al; Global Diabetic Retino- pathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-82.
  9. Catier A, Tadayoni R, Paques M, et al. Characterization of macular ede- ma from various etiologies by optical coherence tomography. Am J Oph- thalmol 2005;140:200-6.
  10. Schatz H, Patz A. Cystoid maculopathy in diabetics. Arch Ophthalmol 1976;94:761-8.
  11. Ciardella AP, Klancnik J, Schiff W, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004;88:1131-6. Browning DJ. Diabetic macular edema: a critical review of the early tre- atment diabetic retinopathy study (ETDRS) series and subsequ